A 72-year-old man who had been receiving oral tofacitinib for 13 months for rheumatoid arthritis presented in August 2022 with a sense of discomfort in his right upper limb and myoclonus-like involuntary movements. On the following day, he was admitted to another hospital after being noted to have right hemiparesis, ataxia of the right upper limb, and involuntary movements.
Brain MRI at that time revealed findings suggestive of cerebral infarction.
From the day after admission, he developed fever and seizures, which progressed to status epilepticus. On the third hospital day, he was transferred to our facility. Upon arrival, he was intubated, mechanically ventilated, and maintained under deep sedation, with no spontaneous limb movement observed.
Although cerebrospinal fluid (CSF) analysis showed no pleocytosis and brain MRI did not reveal the typical temporal lobe lesions, multiplex PCR (FilmArray®) of the CSF was positive for HSV-1, leading to a diagnosis of herpes simplex encephalitis (HSE). Acyclovir treatment, which had been initiated on day 5 of illness, was continued for 21 days.
In elderly or immunosuppressed patients, HSE may present without typical imaging findings or CSF pleocytosis. Therefore, in suspected cases, early implementation of PCR testing and prompt initiation of acyclovir therapy are essential.
View full abstract